– USA, MA – Oncorus, Inc., an oncolytic virus company focused on driving innovation to transform outcomes for cancer patients, today announced the completion of an oversubscribed $79.5 million Series B financing co-led by Cowen Healthcare Investments and Perceptive Advisors, with participation from Oncorus’ syndicate of Series A investors including MPM Capital, UBS Oncology Impact Fund, Deerfield Management, Arkin Bioventures, Celgene and Astellas Venture Management.…
F2G welcomes Tim Anderson, Will West and Naveed Siddiqi to Board along with securing $60m financing led by Cowen Healthcare
– UK, Manchester / AUSTRIA, Vienna – F2G Ltd, a UK- and Austria-based biotech developing novel therapies for life-threatening systemic fungal infections, announced today that it has secured $60.8 million in a financing round led by Cowen Healthcare Investments alongside strong participation from existing investors Novo Holdings, Morningside Ventures, Brace Pharma Capital and Advent Life Sciences.…